These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 31689713)
41. Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome. Coupaye M; Tauber M; Cuisset L; Laurier V; Bieth E; Lacorte JM; Oppert JM; Clément K; Poitou C J Clin Endocrinol Metab; 2016 Dec; 101(12):4895-4903. PubMed ID: 27662437 [TBL] [Abstract][Full Text] [Related]
42. Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome. Dudley O; McManus B; Vogels A; Whittington J; Muscatelli F J Intellect Disabil Res; 2008 May; 52(Pt 5):426-36. PubMed ID: 18298478 [TBL] [Abstract][Full Text] [Related]
43. The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome. Marzullo P; Marcassa C; Campini R; Eleuteri E; Minocci A; Priano L; Temporelli P; Sartorio A; Vettor R; Liuzzi A; Grugni G J Clin Endocrinol Metab; 2005 Oct; 90(10):5639-46. PubMed ID: 16030173 [TBL] [Abstract][Full Text] [Related]
44. Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome: support for normal response to food intake. Kuppens RJ; Delhanty PJ; Huisman TM; van der Lely AJ; Hokken-Koelega AC Clin Endocrinol (Oxf); 2016 Sep; 85(3):488-94. PubMed ID: 26850227 [TBL] [Abstract][Full Text] [Related]
45. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C Growth Horm IGF Res; 2010 Jun; 20(3):179-84. PubMed ID: 20199883 [TBL] [Abstract][Full Text] [Related]
46. Plantar Flexor Function in Adults with and without Prader-Willi Syndrome. Pamukoff DN; Holmes SC; Shumski EJ; Garcia SA; Rubin DA Med Sci Sports Exerc; 2020 Oct; 52(10):2189-2197. PubMed ID: 32936593 [TBL] [Abstract][Full Text] [Related]
47. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial. Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996 [TBL] [Abstract][Full Text] [Related]
48. Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome. Marzullo P; Marcassa C; Minocci A; Campini R; Eleuteri E; Gondoni LA; Aimaretti G; Sartorio A; Scacchi M; Grugni G J Clin Endocrinol Metab; 2015 May; 100(5):2106-14. PubMed ID: 25710568 [TBL] [Abstract][Full Text] [Related]
49. Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome. Grugni G; Crinò A; Bertocco P; Marzullo P Am J Med Genet A; 2009 Feb; 149A(4):726-31. PubMed ID: 19267411 [TBL] [Abstract][Full Text] [Related]
50. Improved Mental and Motor Development During 3 Years of GH Treatment in Very Young Children With Prader-Willi Syndrome. Donze SH; Damen L; Mahabier EF; Hokken-Koelega ACS J Clin Endocrinol Metab; 2018 Oct; 103(10):3714-3719. PubMed ID: 30113638 [TBL] [Abstract][Full Text] [Related]
51. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal. Allen DB; Carrel AL J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076 [TBL] [Abstract][Full Text] [Related]
52. Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS. Damen L; Grootjen LN; Donze SH; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS Eur J Endocrinol; 2021 May; 184(6):773-782. PubMed ID: 33769952 [TBL] [Abstract][Full Text] [Related]
53. Severe tooth wear in Prader-Willi syndrome. A case-control study. Saeves R; Espelid I; Storhaug K; Sandvik L; Nordgarden H BMC Oral Health; 2012 May; 12():12. PubMed ID: 22639910 [TBL] [Abstract][Full Text] [Related]
54. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884 [TBL] [Abstract][Full Text] [Related]
55. Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Patel S; Harmer JA; Loughnan G; Skilton MR; Steinbeck K; Celermajer DS Clin Endocrinol (Oxf); 2007 Jun; 66(6):771-7. PubMed ID: 17437511 [TBL] [Abstract][Full Text] [Related]
56. 25OH vitamin D levels in pediatric patients affected by Prader-Willi syndrome. Fintini D; Pedicelli S; Bocchini S; Bizzarri C; Grugni G; Cappa M; Crinò A J Endocrinol Invest; 2018 Jun; 41(6):739-742. PubMed ID: 29101669 [TBL] [Abstract][Full Text] [Related]
57. Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. Hoybye C; Bruun JM; Richelsen B; Flyvbjerg A; Frystyk J Eur J Endocrinol; 2004 Oct; 151(4):457-61. PubMed ID: 15476445 [TBL] [Abstract][Full Text] [Related]
59. Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition. Höybye C Acta Paediatr; 2015 Apr; 104(4):422-7. PubMed ID: 25557351 [TBL] [Abstract][Full Text] [Related]
60. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. Festen DA; de Weerd AW; van den Bossche RA; Joosten K; Hoeve H; Hokken-Koelega AC J Clin Endocrinol Metab; 2006 Dec; 91(12):4911-5. PubMed ID: 17003096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]